Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Generation Time

Generation Time

Bacterial generation time, the period required for a bacterial population to double during its exponential growth phase, serves as a critical measure of microbial growth dynamics under optimal conditions. This parameter varies significantly across bacterial species and can be influenced by factors such as temperature, pH, and the availability of nutrients. For example, Escherichia coli can achieve a generation time of approximately 20 minutes, while Mycobacterium tuberculosis exhibits a much...

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Trihybrid Crosses

Trihybrid Crosses

Trihybrid Crosses
Some of Mendel’s crosses examined three pairs of contrasting characteristics. Such a cross is called a trihybrid cross. A trihybrid cross is a combination of three individual monohybrid crosses. For example, plant height (tall vs. short), seed shape (round vs. wrinkled), and seed color (yellow vs. green).
The F1 generation plants of a trihybrid cross are heterozygous for all three traits and produce eight gametes. Upon self-fertilization, these gametes have an equal chance to...

IR Frequency Region: Fingerprint Region

IR Frequency Region: Fingerprint Region

IR spectra are divided into two main regions: the diagnostic region and the fingerprint region. The diagnostic region of the spectrum lies above 1500 cm−1. The absorptions resulting from single-bond vibrations of the N–H, C–H, and O–H stretch at higher wavenumbers and appear on the left side of the spectrum. The stretching absorptions of the C≡C and C≡N occur between 2100–2300 cm−1. In contrast, those arising from stretching absorptions of the C=O, C=N, and C=C occur between 1600–1850 cm−1.
The...

FISH - Fluorescent In-situ Hybridization

FISH - Fluorescent In-situ Hybridization

Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...

IV Infusion to Oral Dosing: Conversion Methods

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Is Mediterranean diet associated with severe asthma control? A multi-center cross-sectional study in Greece.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026

Same author

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal of hematology & oncology·2026

Same author

The Impact of Chronic Hand Eczema on Work Productivity and Quality of Life: A Cross-Sectional Study.

International journal of dermatology·2026

Same author

Emerging Insights into Hereditary Alpha-Tryptasemia in the Context of Mast Cell Disorders: A Greek Case Series.

Journal of personalized medicine·2026

Same author

Geographical variability in severe asthma: comparison of patients' characteristics between national, regional, and international cohorts in ISAR.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026

Same author

Editorial: Anaphylaxis challenges: idiopathic and rare causes.

Frontiers in allergy·2026

Search research articles

Related Experiment Video

Updated: May 23, 2026

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

Published on: October 6, 2019

Longer FVIII: the 4th generation.

Michael Makris¹

¹University of Sheffield.

|March 31, 2012

Summary

This summary is machine-generated.

Researchers infused a novel recombinant factor VIII (FVIII) product, fused with an IgG1 Fc fragment, into patients. This innovative treatment demonstrated a significantly extended half-life in the bloodstream, offering potential for improved hemophilia therapy.

More Related Videos

Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins

Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins

Published on: October 28, 2020

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

Related Experiment Videos

Last Updated: May 23, 2026

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

Published on: October 6, 2019

Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins

Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins

Published on: October 28, 2020

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

Area of Science:

Hematology
Protein engineering
Pharmacokinetics

Background:

Hemophilia A is a serious bleeding disorder caused by a deficiency in factor VIII (FVIII).
Current FVIII replacement therapies require frequent infusions due to their short half-life.
Developing FVIII products with prolonged circulation times is a key therapeutic goal.

Purpose of the Study:

To present the first human data on a novel recombinant factor VIII (FVIII) product engineered for extended half-life.
To evaluate the safety and pharmacokinetic profile of this FVIII-Fc fusion protein in humans.

Main Methods:

Infusion of a new recombinant FVIII product fused with the Fc fragment of immunoglobulin G1 (IgG1).
Monitoring of FVIII levels and pharmacokinetic parameters in human subjects.
Assessment of safety and tolerability of the FVIII-Fc fusion protein.

Main Results:

The recombinant FVIII-Fc fusion protein exhibited a significantly prolonged half-life in circulation.
Initial human data suggest a favorable safety profile for the novel FVIII product.
Pharmacokinetic analysis confirmed extended circulation duration compared to standard FVIII products.

Conclusions:

The FVIII-Fc fusion protein represents a promising advancement in hemophilia A treatment.
This engineered FVIII product has the potential to reduce infusion frequency and improve patient outcomes.
Further clinical studies are warranted to confirm the long-term efficacy and safety of this prolonged-acting FVIII therapy.